Clopidogrel Bisulfate tablet bulk supplier for pharma manufacturers

Clopidogrel Bisulfate Tablet 75 mg, 300 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 75 mg, 300 mg

Reference Brands: Plavix(US & EU)

Clopidogrel inhibits the P2Y12 receptor on platelets, preventing ADP-induced activation and aggregation. It reduces the risk of blood clots, stroke, and heart attack, providing effective antiplatelet therapy. Benefits include oral administration, proven efficacy in cardiovascular prevention, and long-term safety for patients at risk of thrombotic events.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Clopidogrel is approved in both the US by the FDA and in the EU through EMA authorization for preventing blood clots in cardiovascular disease. Regulatory approval requires a detailed dossier demonstrating safety, efficacy, pharmacovigilance, and manufacturing quality. In the US, approval involves submission of comprehensive clinical data, while the EU mandates adherence to regional guidelines, including stability and bioequivalence studies. For guidance on dossier preparation, regulatory strategies, and successful market entry, visit PharmaTradz. Ensuring regulatory compliance is essential for the effective and safe commercialization of clopidogrel tablets worldwide, supporting cardiovascular patient care.

Clopidogrel Bisulfate Tablet — third party manufacturing & bulk supply

Clopidogrel Bisulfate Tablet 75 mg, 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Clopidogrel Bisulfate Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Clopidogrel Bisulfate Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Clopidogrel Bisulfate Tablet →

Back to Listing

Frequently Asked Questions

Clopidogrel bisulfate is used to reduce the risk of heart attack and stroke in people with cardiovascular diseases such as recent myocardial infarction, recent stroke, or established peripheral arterial disease. It is also used in patients with acute coronary syndrome to prevent blood clots that can block blood vessels.

Clopidogrel bisulfate is a chemically synthesized antiplatelet agent. It is the bisulfate salt form of clopidogrel, which enhances the stability and bioavailability of the active substance in the body.

Clopidogrel bisulfate is marketed under several trade names globally, the most well-known being Plavix.

The original brand Plavix was developed and marketed by Sanofi and Bristol-Myers Squibb. Today, clopidogrel bisulfate is manufactured by multiple pharmaceutical companies worldwide as both branded and generic versions.

The generic name is clopidogrel bisulfate.

Common brand names include Plavix and various country-specific branded generics.

Clopidogrel bisulfate is manufactured in multiple countries, including the USA, EU nations, India, and other regions, by approved pharmaceutical manufacturers following regulatory standards.